Europe Blood Screening Market Size, Share & Trends Report

Europe Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA, NGS, Western Blotting), By Product (Reagents, Instruments), And Segment Forecasts, 2018 - 2025

  • Published Date: Dec, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-711-7
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 64

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Research Scope and Assumptions
                   1.3 List to Data Sources
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Europe Blood Screening Market Variables, Trends & Scope
                   3.1 Market Segmentation
                   3.2 Europe Blood Screening Market Dynamics
                       3.2.1 Market Driver Analysis
                           3.2.1.1 Growing demand for blood for transfusion
                           3.2.1.2 Stringent Government regulations
                       3.2.2 Market RESTRAINTS Analysis
                           3.2.2.1 Insufficient blood donations
                           3.2.2.2 High operating cost of NAT
                       3.2.3 Penetration & Growth Prospects Mapping
                       3.2.4 Europe Blood Screening Market - PESTLE Analysis
                       3.2.5 Industry Analysis - Porter’s
                   3.3 List of Diagnostic Centres in Europe
                   3.4 Pricing Analysis
Chapter 4 Europe Blood Screening Market: Technology Estimates & Trend Analysis
                   4.1 Europe Blood Screening Market: Technology Movement Analysis
                   4.2 Nucleic Acid Amplification Test (NAT)
                       4.2.1 Europe NAT Market Estimates and Forecasts, 2014 - 2025 (USD Million)
                   4.3 Enzyme-Linked Immunosorbent Assay (ELISA)
                       4.3.1 Europe ELISA market estimates and forecasts, 2014 - 2025 (USD Million))
                   4.4 Chemiluminescence Immunoassay (CLIA)
                       4.4.1 Europe CLIA market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.5 Next-Generation Sequencing (NGS)
                       4.5.1 Europe NGS market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.6 Western Blotting
                       4.6.1 Europe western blotting market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Europe Blood Screening Market: Product Estimates & Trend Analysis
                   5.1 Europe Blood Screening Market: Product Movement Analysis
                   5.2 Reagents
                       5.2.1 Europe reagents market estimates and forecasts, 2014 - 2025 (USD Million)
                   5.3 Instruments
                       5.3.1 Europe instruments market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Europe Blood Screening Market: Regional Estimates & Trend Analysis, by Technology & Products
                   6.1 Europe Blood Screening Market: Regional Movement Analysis, 2017 & 2025, USD Million
                   6.2 Europe
                       6.2.1 Europe blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
                       6.2.2 U.K.
                           6.2.2.1 U.K. blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
                       6.2.3 Germany
                           6.2.3.1 Germany blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
                       6.2.4 France
                           6.2.4.1 France blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
                       6.2.5 Italy
                           6.2.5.1 Italy blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
                       6.2.6 SPAIN
                           6.2.6.1 Spain blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                   7.1 Strategic Framework
                   7.2 Europe Blood Screening Market: Market Position Analysis (Based on Application, Product Benchmarking, Regional Presence, and Recent Updates)
                   7.3 Company Profiles
                       7.3.1 Roche Diagnostics
                           7.3.1.1 Company Overview
                           7.3.1.2 Financial performance
                           7.3.1.3 Product benchmarking
                           7.3.1.4 Strategic initiatives
                       7.3.2 Bio-Rad Laboratories, Inc.
                           7.3.2.1 Company Overview
                           7.3.2.2 Financial performance
                           7.3.2.3 Product benchmarking
                           7.3.2.4 Strategic initiatives
                       7.3.3 Siemens Healthcare GmBH
                           7.3.3.1 Company Overview
                           7.3.3.2 Financial performance
                           7.3.3.3 Product benchmarking
                           7.3.3.4 Strategic initiatives
                       7.3.4 Grifols, S.A.
                           7.3.4.1 Company Overview
                           7.3.4.2 Financial performance
                           7.3.4.3 Product benchmarking
                           7.3.4.4 Strategic initiatives
                       7.3.5 Becton, Dickinson and Company
                           7.3.5.1 Company Overview
                           7.3.5.2 Financial performance
                           7.3.5.3 Product benchmarking
                           7.3.5.4 Strategic initiatives
                       7.3.6 Agilent Technologies
                           7.3.6.1 Company Overview
                           7.3.6.2 Financial performance
                           7.3.6.3 Product benchmarking
                       7.3.7 Thermo Fisher Scientific, Inc.
                           7.3.7.1 Company Overview
                           7.3.7.2 Financial performance
                           7.3.7.3 Product benchmarking
                           7.3.7.4 Strategic initiatives
                       7.3.8 Danaher
                           7.3.8.1 Company Overview
                           7.3.8.2 Financial performance
                           7.3.8.3 Product benchmarking
                           7.3.8.4 Strategic initiatives


List of Table

Table 1 Europe Blood Screening Market: Pricing Analysis, 2017
Table 2 Europe blood screening market, by country, 2014 - 2025 (USD Million)
Table 3 Europe blood screening market, by technology, 2014 - 2025 (USD Million)
Table 4 Europe blood screening market, by product, 2014 - 2025 (USD Million)
Table 5 U.K. blood screening market, by technology, 2014 - 2025 (USD Million)
Table 6 U.K. blood screening market, by product, 2014 - 2025 (USD Million)
Table 7 Germany blood screening market, by technology, 2014 - 2025 (USD Million)
Table 8 Germany blood screening market, by product, 2014 - 2025 (USD Million)
Table 9 France blood screening market, by technology, 2014 - 2025 (USD Million)
Table 10 France blood screening market, by product, 2014 - 2025 (USD Million)
Table 11 Italy blood screening market, by technology, 2014 - 2025 (USD Million)
Table 12 Italy blood screening market, by product, 2014 - 2025 (USD Million)
Table 13 Spain blood screening market, by technology, 2014 - 2025 (USD Million)
Table 14 Spain blood screening market, by product, 2014 - 2025 (USD Million)


List of Figures

Fig.1 Europe Blood Screening market: Market snapshot, USD Million, 2017
Fig.2 Europe blood screening market segmentation
Fig.3 Europe Blood Screening market dynamics
Fig.4 Europe Blood Screening market driver impact
Fig.5 Fig.4 Europe Blood Screening market restraints impact
Fig.6 Penetration & Growth Prospects Mapping
Fig.7 Europe Blood Screening market - PESTLE Analysis
Fig.8 Industry Analysis - Porter’s
Fig.9 Europe Blood Screening market, Technology outlook: key takeaways, USD Million
Fig.10 Europe Blood Screening market: Technology movement analysis (USD Million)
Fig.11 Europe NAT market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.12 Europe ELISA market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.13 Europe CLIA market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.14 Europe NGS market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.15 Europe western blotting market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.16 Europe Blood Screening Market, Product outlook key takeaways (USD Million)
Fig.17 Europe Blood Screening Market: Product movement analysis (USD Million)
Fig.18 Europe reagents market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.19 Europe instruments market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.20 Regional market place: Key takeaways
Fig.21 Europe blood screening market: Country movement analysis (USD Million)
Fig.22 Europe blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.23 U.K. blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.24 Germany blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.25 France blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.26 Italy blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.27 Spain blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.28 Strategic framework
Fig.29 Europe Blood Screening Market: Market Position Analysis

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.